This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $300 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoLive In-Person Event: December 4 - 8, 2022

Kalyani Mondal, Ph.D.
Associate Director, Biosensors at Charles River Laboratories


Kalyani is a protein biochemist with extensive industry experience in antibody biophysical characterization and assay development with special focus on biosensor/label-free methodologies. Along with antibody discovery work (HT affinity screen, epitope binning), Kalyani also has experience with SPR-based characterization of bispecifics, ADCs, Fc engineering, and Ab stressed samples. Kalyani currently manages the Biosensors group out of the South San Francisco Antibody Discovery site.

Agenda Sessions

  • From Lead Discovery through Optimization and Validation: A Case Study in Rapid Antibody Discovery